In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Pharmaceutical and Biotechnology Environmental Monitoring market for 2018-2023.
Environmental monitoring during pharmaceutical and biopharmaceutical production is crucial for ensuring the safety of formulated drug products. While requirements for the control of both viable (living microorganisms) and non-viable particles (e.g. dust, hair, etc.) and other contaminants (i.e. trace metals, volatiles, etc.) for aseptic manufacturing operations are more extensive than those for non-sterile processes, the quantity of samples that must be analyzed and the amount of data generated can be daunting regardless of the final drug form, particularly for global companies with multiple production facilities.
This report studies the Pharmaceutical and Biotechnology Environmental Monitoring market. It covered Monitoring Equipment, Media, Reagents and Kits, Microbiology Services, Environmental Monitoring and Software used in Pharmaceutical and Biotechnology Environmental Monitoring.
The classification of Pharmaceutical and Biotechnology Environmental Monitoring includes Monitoring Equipment, Media, Software and Microbiology Services, the proportion of Monitoring Equipment in 2017 is about 31%.
Pharmaceutical and Biotechnology Environmental Monitoring is widely used in Pharmaceutical Industry, Biotechnology Industry and Academic and Research Institutes. The most proportion of Pharmaceutical and Biotechnology Environmental Monitoring is Pharmaceutical Industry, and the proportion in 2017 is 50%. The trend of dental clinic is decreasing.
North America is the largest market for Pharmaceutical and Biotechnology Environmental Monitoring, with a market share nearly 42% in 2017. Following North America, Europe is the second largest market with the consumption market share of 26%.
Over the next five years, LPI(LP Information) projects that Pharmaceutical and Biotechnology Environmental Monitoring will register a 6.8% CAGR in terms of revenue, reach US$ 1100 million by 2023, from US$ 740 million in 2017.
This report presents a comprehensive overview, market shares and growth opportunities of Pharmaceutical and Biotechnology Environmental Monitoring market by product type, application, key companies and key regions.
To calculate the market size, LP Information considers value generated from the sales of the following segments:
Segmentation by product type:
Monitoring Equipment
Media
Microbiology Services
Segmentation by application:
Pharmaceutical Industry
Biotechnology Industry
Academic and Research Institutes
We can also provide the customized separate regional or country-level reports, for the following regions:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East and Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Danaher CorporationÂ
Thermo Fisher Scientific
Merck KGaA
Eurofins Sinensis
Lonza
Biomerieux
VAI
Cosasco
RMONI
Amphenol Advanced Sensors
Vaisala
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Pharmaceutical and Biotechnology Environmental Monitoring market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Pharmaceutical and Biotechnology Environmental Monitoring market by identifying its various subsegments.
Focuses on the key global Pharmaceutical and Biotechnology Environmental Monitoring players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pharmaceutical and Biotechnology Environmental Monitoring with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Pharmaceutical and Biotechnology Environmental Monitoring submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Single User License – Only one user can access this report at time, users are not allowed to take a print out of the report PDF.
Enterprise User License – This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish to receive the hard copy version of this report.
Multi User License – This license will be allowing up to five users have access to the product. The report will be emailed to you. The report is sent in PDF format.
Site License – This is a site license, allowing all users within a given geographical location of your organisation access to the product. The report will be emailed to you. The report is sent in PDF format.
